Intervention (N=103) | Control (N=101) | Effect size | |||||||
Primary outcome: BPDSI | |||||||||
M | SD | M | SD | Adjusted mean difference | 95% CI | P value | Cohen’s d | 95% CI | |
Baseline | 34.05 | 7.77 | 33.84 | 7.16 | n.a. | −0.03 | −0.30 to 0.25 | ||
3 months | 27.85 | 7.42 | 29.47 | 8.40 | 1.50 | −0.42 to 3.42 | 0.13 | 0.20 | −0.07 to 0.48 |
6 months | 26.98 | 8.36 | 26.97 | 9.27 | 0.57 | −1.73 to 2.88 | 0.62 | 0.00 | −0.28 to 0.27 |
12 months | 23.49 | 7.50 | 25.69 | 8.69 | 2.34 | 0.02 to 4.66 | <0.05 | 0.27 | 0.00 to 0.55 |
Main safety outcome: SAE | |||||||||
n | % | n | % | Wald χ21 | P value | OR | 95% CI | ||
Baseline | 29 | 29.0 | 30 | 29.4 | n.a. | 0.98 | 0.53 to 1.82 | ||
3 months | 17 | 24.6 | 23 | 32.4 | 1.037 | 0.31 | 0.68 | 0.32 to 1.42 | |
6 months | 22 | 28.6 | 18 | 30.5 | 0.081 | 0.77 | 0.90 | 0.42 to 1.91 | |
12 months | 21 | 28.0 | 12 | 19.7 | 1.213 | 0.27 | 1.58 | 0.70 to 3.54 |
BPDSI, borderline personality disorder severity index; M, mean; n.a., not applicable; SAE, serious adverse event.